Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 07/22 05:35:17 pm
1659.5 GBp   +1.31%
07/22GLAXOSMITHKLINE : half-yearly earnings release
07/20DJBrexit Fears and Weak Pound Weigh on Corporate Europe
07/19 APPLE : GlaxoSmithKline partner for arthritis study
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Sales26 50523 00623 92326 34027 41128 647
Operating income (EBITDA)8 8838 0457 0288 6568 9999 534
Operating profit (EBIT)8 0156 5945 7296 6847 2468 039
Pre-Tax Profit (EBT)6 6472 96810 5264 3925 2556 125
Net income5 6282 7568 4222 8033 5744 396
P/E ratio0,150,240,0832,323,619,5
EPS (PNC )11156,717251,470,485,2
Dividend per Share (PNC )78,080,080,080,980,081,1
Yield484%581%583%4,88%4,82%4,88%
Reference price (PNC )16.113.813.71659.51659.51659.5
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Debt12 64514 37710 72712 84312 77512 243
Finance------
Operating income (EBITDA)8 8838 0457 0288 6568 9999 534
Leverage
(Debt/EBITDA)
1,42x1,79x1,53x1,48x1,42x1,28x
Capital Expenditure1 1881 1881 3801 6531 4861 484
Book Value Per Share (BVPS)146 PNC87,6 PNC106 PNC72,2 PNC78,2 PNC91,3 PNC
Cash Flow per Share149 PNC108 PNC53,2 PNC108 PNC129 PNC138 PNC
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 80 857 M GBP -
Entreprise Value (EV) 93 700 M GBP 93 632 M GBP
Valuation 2016e 2017e
P/E ratio (Price / EPS) 32,3x 23,6x
Capitalization / Revenue 3,07x 2,95x
EV / Revenue 3,56x 3,42x
EV / EBITDA 10,8x 10,4x
Yield (DPS / Price) 4,88% 4,82%
Price to book (Price / BVPS) 23,0x 21,2x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 25,4% 26,4%
operating Leverage (Delta EBIT / Delta Sales) 1,65x 2,07x
Net Margin (Net Profit / Revenue) 10,6% 13,0%
ROA (Net Profit / Asset) 7,54% 9,12%
ROE (Net Profit / Equities) 90,9% 119%
Rate of Dividend 157% 114%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   6,27% 5,42%
Cash Flow / Sales 20,1% 23,0%
Capital Intensity (Assets / Sales) 1,41x 1,43x
Financial Leverage (Net Debt / EBITDA) 1,48x 1,42x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend